#United States #investor conference #TransMedics #Andover #organ transplant

TransMedics to Participate in June Investor Conferences

TransMedics Group, Inc. (Nasdaq: TMDX), a pioneering medical technology firm based in Andover, Massachusetts, is making waves in the organ transplant sector. On May 20, 2025, the company announced its participation in two noteworthy investor conferences scheduled for June. This participation aims to highlight their innovative solutions in organ transplantation for patients suffering from end-stage heart, lung, and liver failure.

Upcoming Events

TransMedics will feature at the following conferences:
1. William Blair 45th Annual Growth Stock Conference
- Date: Tuesday, June 3, 2025
- Time: 5:00 PM EST
- Location: Chicago

2. Goldman Sachs 46th Annual Global Healthcare Conference
- Date: Monday, June 9, 2025
- Time: 8:00 AM EST
- Location: Miami

These events will present a prime opportunity for TransMedics management to discuss the company’s vision and revolutionary technology that is reshaping organ transplant therapy. The conferences are particularly timely, as they come on the heels of TransMedics’ continuous innovations and overwhelming demand for improved organ transplant solutions.

Webcast Availability

For those unable to attend, a live webcast of TransMedics' presentations will be accessible on the ‘Investors’ section of their official website. This will allow investors and stakeholders to stay informed and engaged with the company’s developments. An archived version of the presentation will also be available post-event.

About TransMedics Group, Inc.

TransMedics stands at the forefront of the portable extracorporeal warm perfusion process, which enhances the assessment and preservation of donor organs prior to transplantation. Their cutting-edge technologies are developed with an emphasis on addressing the critical shortage of quality organs for transplant, making significant strides in the quest to improve organ viability and increase utilization rates.

Founded to meet the pressing need for better organ transplant options, TransMedics aims to alleviate the challenges faced by patients in need of heart, lung, or liver transplants. Their persistent focus on innovation seeks to change the transplantation landscape permanently, fostering improved outcomes for patients in dire need of lifesaving procedures.

As such, the company's participation in these investor conferences is not merely about numerical growth, but also a commitment to transforming the field of organ transplantation. Their advancements are expected to generate significant interest among investors, healthcare professionals, and patients alike.

Investor Contact Information

For further information, TransMedics encourages interested parties to reach out directly to their investor relations team:

• - Brian Johnston
• - Laine Morgan
• - Contact Number: 332-895-3222
• - Email: contact@transmedics.com

As TransMedics gears up for these conferences, the medical community and investors alike are keenly watching to see how their advancements can reshape the future of organ transplantation. The potential for enhanced organ viability and the increased availability of organs for transplant represent a significant leap forward.

In conclusion, the upcoming June conferences pose a critical platform for TransMedics to not only showcase its accomplishments but also to forge meaningful connections with investors who share a vision of future advancements in healthcare technology. With the influence and connections made at such events, TransMedics is poised to ensure that organ transplant innovation remains at the forefront of medical advances for years to come.